Patents Assigned to Research Development
  • Patent number: 9926657
    Abstract: A dimensionally stable floor covering comprises a tufted textile substrate and a reinforcement layer attached to the textile substrate. The reinforcement layer includes an adhesive backing compound and reinforcement fibers surrounded by the adhesive backing. The fibers may form a continuous layer on the back side of the floor covering or may be dispersed within the adhesive backing compound. The adhesive backing compound may be hot water-soluble to facilitate recycling of the floor covering. The floor covering may optionally include additional backing layers (including cushions) and may be used as a broadloom carpet, a carpet tile, or other modular floor covering products. Methods of manufacturing, installing, and recycling the present floor coverings are also provided.
    Type: Grant
    Filed: October 19, 2016
    Date of Patent: March 27, 2018
    Assignee: Higgins Research & Development, LLC
    Inventor: Kenneth B. Higgins
  • Publication number: 20180079803
    Abstract: The present invention concerns VLPT immunoreactive compositions for E. chaffeensis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. chaffeensis VLPT are disclosed.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 22, 2018
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Tian LUO
  • Publication number: 20180080875
    Abstract: Photoluminescence from a sample detector is detected using an array of photo-sensitive detectors. At least one first photo-sensitive detector of the array is provided with a first type of linear polarization filter and at least one second photo-sensitive detector is provided with a second type of linear polarization filter. The first type of linear polarization filter has a plane of polarization which is at angled with respect to a plane of polarization of said second type of polarization filter.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 22, 2018
    Applicant: STMicroelectronics (Research & Development) Limited
    Inventors: Francescopaolo Mattioli Della Rocca, John Kevin Moore
  • Patent number: 9919586
    Abstract: The present invention relates to an air nozzle device (10) for a vehicle (1) comprising a housing (11) defining an interior volume and having an air inlet (12) at one side, an air discharge opening (14) at a second side and an air flow channel (18) through the housing (11) for transporting a flow of air between the air inlet and the air discharge opening, the device (10) further comprising a moveable operating member (30), a shutoff mechanism (40) and an air flow adjustment arrangement (20), said shutoff mechanism (40) being pivotably connected to said housing and configured to regulate the air flow and said air flow adjustment arrangement (20) being pivotably connected to said housing and configured to adjust the direction of the air flow in a longitudinal direction X and in a vertical direction Z, wherein said operating member (30) comprising a user-actuated manual mechanism (32), a first linkage member (34) and a second linkage member (36), wherein said user-actuated manual mechanism (32) is arranged downs
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: March 20, 2018
    Assignee: Ningbo Geely Automobile Research & Development Co., Ltd
    Inventor: Lionel Belzons
  • Patent number: 9914173
    Abstract: A particle production apparatus including a generating device, a conveying device, and a straightening device is provided. The generating device includes a tank filled with a dense medium, an electric power source, a first and a second electrical conducting element received in the dense medium and coupled to an anode and a cathode of the electric power source respectively. The conveying device is configured to convey a metal wire into the tank and make the metal wire to contact the first electrical conducting element and the second electrical conducting element in a straight-line direction, so as to produce an electric explosion to form a plurality of particles in the dense medium.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: March 13, 2018
    Assignee: Metal Industries Research & Development Centre
    Inventors: Tai-Hsin Hsu, Yin Chuang, Wen-Pin Chien, Chi-Ming Chang, Ho-Chung Fu, Chang-Pen Chen
  • Patent number: 9913813
    Abstract: Aqueous compositions suitable for topical administration to the human or animal eye contain at least one water-soluble polymeric ophthalmic lubricant, such as hyaluronate, carbomer gel or hypromellose, together with a water-soluble analgesic. The analgesic may be an opiod, particularly an opioid having an affinity for 5-HT receptors, such as tramadol. The aqueous compositions may for example be used as artificial tears, and as general ophthalmic lubricants for treating conditions such as dry eye or blepharitis. Further compositions combine ophthalmologicallyactive agents, such as pharmaceuticals, with opioids, such as tramadol in particular. These compositions may be used to treat the eye while reducing pain or discomfort that would normally be produced by administering these particular pharmaceuticals to the eye, and increasing the efficacy of the pharmaceuticals.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: March 13, 2018
    Assignee: Optosolve Research & Development Limited
    Inventor: Anant Sharma
  • Publication number: 20180065842
    Abstract: Provided is a self-processing synthesis of hybrid nanostructures, novel nanostructures and uses thereof in the construction of electronic and optoelectronic devices.
    Type: Application
    Filed: April 21, 2016
    Publication date: March 8, 2018
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Roie YERUSHALMI, Yossef PALTIEL, Ori PINCHAS-HAZUT, Sharon WAICHMAN, Amir ZIV, Shira YOCHELIS
  • Publication number: 20180064743
    Abstract: A new class of paromomycin-derived aminoglycosides, which exhibit efficient stop-codon mutation suppression activity, low toxicity and high selectivity towards eukaryotic cells are provided. Also provided are chemical and chemo-enzymatic processes of preparing these paromomycin-derived aminoglycosides and intermediates thereof, as well as pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders.
    Type: Application
    Filed: November 20, 2017
    Publication date: March 8, 2018
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Timor BAASOV, Tamar BEN-YOSEF, Igor NUDELMAN, Annie REBIBO-SABBAH, Dalia SHALLOM-SHEZIFI, Mariana HAINRICHSON
  • Publication number: 20180066227
    Abstract: A method of expanding and maintaining human embryonic stem cells (ESCs) in an undifferentiated state by culturing the ESCs in a suspension culture under culturing conditions devoid of substrate adherence is provided. Also provided are a method of deriving ESC lines in the suspension culture and methods of generating lineage-specific cells from ESCs which were expanded in the suspension culture of the present invention.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 8, 2018
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Michal AMIT, Joseph ITSKOVITZ-ELDOR
  • Patent number: 9901619
    Abstract: A method of treating or preventing an ovary-related syndrome associated with infertility in a subject in need thereof is provided. The method comprising administering to the subject a pharmaceutical composition comprising an active ingredient consisting of pigment epithelium-derived factor (PEDF) and a pharmaceutically acceptable carrier, thereby treating or preventing the ovary-related syndrome associated with infertility in the subject.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: February 27, 2018
    Assignees: Ramot at Tel-Aviv University Ltd., The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center
    Inventors: Ruth Shalgi, Dana Chuderland, Ido Ben-Ami, Raphael Ronel
  • Patent number: 9906486
    Abstract: A method for managing communication among a plurality of social network members. The method comprises defining a multi participant task, setting at least one forward rule limiting the distribution an invitation message for participating in the multi participant task, forwarding the invitation message to at least one addressee from a plurality of social network members, allowing the at least one addressee to forward the invitation message to at least one additional addressee from the plurality of social network members under the at least one forward rule, monitoring a plurality of feedbacks to the invitation message to determine whether the multi participant task is achieved, and updating a status of the multi participant task according to the determination.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: February 27, 2018
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Oded Shmueli, Royi Ronen
  • Publication number: 20180053798
    Abstract: A hybrid analog-digital pixel circuit is fabricated on two wafers. A first wafer includes the analog pixel circuitry and a second wafer includes the digital control and processing circuitry. Externally accessible contact structures for electrically interconnecting the two wafers are arranged in groups. Each group includes externally accessible contact structures for carrying signals associated solely with operation of a corresponding pixel.
    Type: Application
    Filed: October 16, 2017
    Publication date: February 22, 2018
    Applicant: STMicroelectronics (Research & Development) Limited
    Inventor: Jeffrey M. Raynor
  • Publication number: 20180043036
    Abstract: Provided are modified lipid compounds and their use in the formation of lipid assemblies. Also provided are lipid assemblies including (a) an amphoteric lipid including in covalent association with (i) one or more acyl chains; (ii) one or more weak base moiety; (iii) one or more weak acid moiety; the lipid assembly also including (b) one or more additional lipids, at least one of which being a zwitterionic lipid. In some embodiments, the amphoteric lipid is a compound including (a) a tri-functional moiety; (b) two non-phosphate lipid chains associated with two of the functional moieties of said tri-functional moiety; (c) optionally a spacer moiety associated with the third of the functional moieties of said tri-functional moiety; and (d) a polyalkylamine optionally including a short peptide with one to several carboxylic acid residues. Further provided are the uses of the lipid assembly, inter alia, for transfection or cancer treatment.
    Type: Application
    Filed: February 4, 2016
    Publication date: February 15, 2018
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., QBI Enterprises Ltd., Rosetta Genomics, Biolab Ltd.
    Inventors: Sharon AVKIN-NACHUM, Tirtsa KLEINMAN, Noga YERUSHALMI, Yechezkel BARENHOLZ, Rivka COHEN, Kirill MAKEDONSKI, Eylon YAVIN, Andreas Ingemann JENSEN, Keren TURJEMAN
  • Publication number: 20180046386
    Abstract: A method for reducing disk read rate by managing dataset mapping of virtual machine (VM) guest memory, comprising: monitoring a plurality of disk read write operations of a VM guest; updating a dataset mapping between disk blocks allocated to the VM guest and corresponding physical addresses of memory pages of the VM guest containing replica of data stored in the disk blocks, based on the plurality of disk read write operations; when identifying writing to one of the memory pages, removing a mapping of corresponding disk block and corresponding physical address of memory page; when reclaiming a mapped memory page of the VM guest by a host of the VM guest, discarding data contained in the memory page; and when the data is requested by the VM guest after it was reclaimed by said host, retrieving the data from corresponding disk block according to the mapping.
    Type: Application
    Filed: October 3, 2017
    Publication date: February 15, 2018
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Assaf SCHUSTER, Nadav AMIT, Dan TSAFRIR
  • Patent number: 9891428
    Abstract: An optical measurement system including a two-dimensional sine wave annuls grating and a measurement unit is provided. The two-dimensional sine wave annuls grating includes a rotary shaft and a plurality of sine wave structures surrounding the rotary shaft and continuously arranged. The measurement unit is adapted to output a light beam towards the two-dimensional sine wave annuls grating, wherein each of the sine wave structures is adapted to reflect the light beam from the two-dimensional sine wave annuls grating back to the measurement unit. A measurement method for errors of a rotating platform and a two-dimensional sine wave annuls grating are also provided.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: February 13, 2018
    Assignee: Metal Industries Research & Development Centre
    Inventors: Hsiu-An Tsai, Nai-Chun An
  • Patent number: 9889018
    Abstract: Expandable vertebral body implants, systems, instruments, and methods of assembly and using the implants, systems, and instruments are disclosed. The vertebral body implant includes a body with a first end and a second end, a first rotating member rotatably coupled to the first end, wherein an end includes a plurality of first notches inset into the first rotating member, a second rotating member rotatably coupled to the second end, wherein an end includes a plurality of second notches inset into the second rotating member, a first extension member moveably coupled to the first end, and a second extension member moveably coupled to the second end. The expandable cage system comprises a vertebral body implant and an insertion instrument. Methods for assembling and using the vertebral body implants and instruments are also disclosed.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: February 13, 2018
    Assignee: MUSC Foundation for Research Development
    Inventors: Mark Evald Semler, Bruce Frankel, Joseph Ruscito
  • Publication number: 20180037607
    Abstract: Synthetic peptides containing chemical modifications having anti-tumor properties are provided. Further provided are pharmaceutical compositions including the peptides and use thereof for treating proliferative and neoplastic diseases such as cancer.
    Type: Application
    Filed: February 7, 2016
    Publication date: February 8, 2018
    Applicant: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventor: Uri WORMSER
  • Patent number: 9884982
    Abstract: An abrasive grain made from melted spherical corundum where the abrasive grain consists of a spherical corundum core, coated with an encircling layer of a binder and fine-grained abrasive solid particles.
    Type: Grant
    Filed: April 25, 2007
    Date of Patent: February 6, 2018
    Assignee: Center for Abrasives and Refractories Research & Development C.A.R.R.D. GmbH
    Inventor: Sebastian Sachse
  • Patent number: 9884066
    Abstract: Compositions and methods for treating diseases or disorders associated with the metabolic syndrome using conjugates of bile acids with basic amino acids or a decarboxylated amino acid such as agmatine are provided. Further provided are bile acid-basic amino acid conjugates including chenodeoxycholic acid with an amino acid selected from arginine, lysine, histidine, ornithine or a decarboxylated amino acid such as agmatine.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: February 6, 2018
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Oren Tirosh, Ira Voloshin, Shlomo Sasson, Michal Obercyger, Zecharia Madar
  • Publication number: 20180028604
    Abstract: Semaphorin 3A and uses thereof for treatment of IBD are provided. Further provided is assessing IBD severity or treatment efficacy, including determining Semaphorin 3A levels in a biological sample of a subject afflicted with IBD.
    Type: Application
    Filed: February 9, 2016
    Publication date: February 1, 2018
    Applicant: Medical Research & Development Fund for Health Services Bnai Zion Medical Center
    Inventors: Zahava VADASZ, Elias TOUBI